Influenza News and Research

Latest Influenza News and Research

Specific genetic target could help explain the variation in COVID-19 effects

The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified a specific genetic target that could help explain the tremendous variation in how sick those infected with COVID-19 become.

17 Dec 2020

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

As researchers continue to search for antivirals to counter COVID-19, a study presents the potential utility of a decoction called Respiratory Detox Shot (RDS).

16 Dec 2020

Chemical found in cigarettes could increase severity of COVID-19, new study finds

A new study has found that high levels of the chemical cadmium, is associated with an increased risk of death in patients with influenza or pneumonia.

16 Dec 2020

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.

16 Dec 2020

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.

16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu

Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month.

15 Dec 2020

Drug may increase vaccine protection in older adults

A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows.

15 Dec 2020

Flavobac™ Cold & Flu Guard provides a natural barrier against bacteria and viruses

Flavobac Cold & Flu Guard, developed by leading preventative dentistry provider Oraldent, is a completely natural oral and nasal barrier against bacteria and viruses, including SARS-CoV-2 and influenza.

15 Dec 2020

Pediatricians want kids to be part of COVID vaccine trials

If clinical trials for COVID-19 vaccines aren't expanded soon to include children, it's unlikely that even kids in their teens will be vaccinated in time for the next school year.

15 Dec 2020

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

A machine learning algorithm developed by the Oxford Vaccine Group promises more effective vaccine development for several diseases, including COVID-19.

15 Dec 2020

EUROIMMUN receives CE mark for new PCR test to differentiate between COVID-19 and flu

EUROIMMUN today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of viruses.

From Revvity 15 Dec 2020

UV-LEDs can efficiently, quickly kill coronavirus

Researchers from Tel Aviv University (TAU) have proven that the coronavirus can be killed efficiently, quickly, and cheaply using ultraviolet (UV) light-emitting diodes (UV-LEDs). They believe that the UV-LED technology will soon be available for private and commercial use.

14 Dec 2020

Study: First week and a half after leaving hospital may be dangerous for COVID-19 patients

In the first months after their COVID-19 hospital stay, patients face a high risk of ongoing health problems, trips back to the hospital, and death, a growing number of studies has shown.

14 Dec 2020

Point-of-care testing for influenza can lead to better treatment, faster patient recovery

Southampton-led research has shown that implementing point-of-care testing in hospitals to diagnose influenza can lead to better treatment and faster recovery for patients.

14 Dec 2020

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

A new study suggests an impact of the COVID-19 vaccine on SARS-CoV-2 attack rate, and hospitalizations, even with no protection against infection.

14 Dec 2020

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Scientists have suggested that a proportion of the population have pre-existing immunity to COVID-19 because of T cells primed against SARS-CoV-2 antigens.

14 Dec 2020

Pre-existing immunity shapes a person's antibody response to influenza viruses

New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected.

11 Dec 2020

Favipiravir does not attenuate the progression of COVID-19

Scientists have conducted an observational study to evaluate the efficacy of an anti-influenza medicine favipiravir in treating hospitalized COVID-19 patients.

11 Dec 2020

IGC researchers receive three out of six European Research Council grants

Since the establishment of the European Research Council in 2008, the IGC has secured 17 of their competitive grants (7 Starting, 8 Consolidator and 2 Advanced).

10 Dec 2020

Influenza News and Research

Latest Influenza News and Research

Specific genetic target could help explain the variation in COVID-19 effects

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Chemical found in cigarettes could increase severity of COVID-19, new study finds

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

RedHill Biopharma announces promising preliminary results from opaganib study

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu

Drug may increase vaccine protection in older adults

Flavobac™ Cold & Flu Guard provides a natural barrier against bacteria and viruses

Pediatricians want kids to be part of COVID vaccine trials

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

EUROIMMUN receives CE mark for new PCR test to differentiate between COVID-19 and flu

UV-LEDs can efficiently, quickly kill coronavirus

Study: First week and a half after leaving hospital may be dangerous for COVID-19 patients

Point-of-care testing for influenza can lead to better treatment, faster patient recovery

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Pre-existing immunity shapes a person's antibody response to influenza viruses

Favipiravir does not attenuate the progression of COVID-19

IGC researchers receive three out of six European Research Council grants

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Influenza News and Research

Latest Influenza News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in